2021 Viral Vector Manufacturing for Cell and Gene Therapies
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added...
Stay updated with breaking news from Viral Vector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added...
/PRNewswire/ -- GPB Scientific, Inc., a key enabling technology company for cell therapy manufacturing, announced the hiring of Gaurav Vij and Joan Haab, PhD,...
A new study did not conclusively correlate the incidence of myocarditis or pericarditis with mRNA vaccination against SARS-CoV-2.
Global Viral and Non-Viral Vector Manufacturing Market to Reach $27. 03 Billion by 2031. ...
A recent review article discusses recent advances in protein-based nanoparticle vaccines against SARS-CoV-2.